Literature DB >> 20139249

The radiation protection and therapy effects of mesenchymal stem cells in mice with acute radiation injury.

K X Hu1, Q Y Sun, M Guo, H S Ai.   

Abstract

The aim of this study was to investigate the effects and mechanisms of mesenchymal stem cells (MSCs) on haematopoietic reconstitution in reducing bone marrow cell apoptosis effects in irradiated mice, and to research the safe and effective dosage of MSCs in mice with total body irradiation (TBI). After BALB/c mice were irradiated with 5.5 Gy cobalt-60 gamma-rays, the following were observed: peripheral blood cell count, apoptosis rate, cell cycle, colony-forming unit-granulocyte macrophage (CFU-GM) and colony-forming unit-fibroblast (CFU-F) counts of bone marrow cells and pathological changes in the medulla. The survival of mice infused with three doses of MSCs after 8.0 Gy or 10 Gy TBI was examined. The blood cells recovered rapidly in the MSC groups. The apoptotic ratio of bone marrow cells in the control group was higher at 24 h after radiation. A lower ratio of G0/G1 cell cycle phases and a higher ratio of G2/M and S phases, as well as a greater number of haematopoietic islands and megalokaryocytes in the bone marrow, were observed in the MSC-treated groups. MSCs induced recovery of CFU-GM and CFU-GM and improved the survival of mice after 8 Gy TBI, but 1.5 x 10(8) kg(-1) of MSCs increased mortality. These results indicate that MSCs protected and treated irradiated mice by inducing haematopoiesis and reducing apoptosis. MSCs may be a succedaneous or intensive method of haematopoietic stem cell transplantation under certain radiation dosages, and could provide a valuable strategy for acute radiation syndrome.

Entities:  

Mesh:

Year:  2010        PMID: 20139249      PMCID: PMC3487250          DOI: 10.1259/bjr/61042310

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  41 in total

1.  Infusion of allogeneic-related HLA mismatched mesenchymal stem cells for the treatment of incomplete engraftment following autologous haematopoietic stem cell transplantation.

Authors:  L Fouillard; A Chapel; D Bories; S Bouchet; J-M Costa; H Rouard; P Hervé; P Gourmelon; D Thierry; M Lopez; N C Gorin
Journal:  Leukemia       Date:  2007-01-25       Impact factor: 11.528

2.  Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease.

Authors:  Rosa Yañez; María Luisa Lamana; Javier García-Castro; Isabel Colmenero; Manuel Ramírez; Juan A Bueren
Journal:  Stem Cells       Date:  2006-07-27       Impact factor: 6.277

3.  Radiation-induced cell cycle delays and p53 status of early passage melanoma cell lines.

Authors:  J Parmar; E S Marshall; G A Charters; K M Holdaway; A N Shelling; B C Baguley
Journal:  Oncol Res       Date:  2000       Impact factor: 5.574

4.  Multilineage potential of adult human mesenchymal stem cells.

Authors:  M F Pittenger; A M Mackay; S C Beck; R K Jaiswal; R Douglas; J D Mosca; M A Moorman; D W Simonetti; S Craig; D R Marshak
Journal:  Science       Date:  1999-04-02       Impact factor: 47.728

5.  Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients.

Authors:  M Galotto; G Berisso; L Delfino; M Podesta; L Ottaggio; S Dallorso; C Dufour; G B Ferrara; A Abbondandolo; G Dini; A Bacigalupo; R Cancedda; R Quarto
Journal:  Exp Hematol       Date:  1999-09       Impact factor: 3.084

6.  Long-term expansion and maintenance of cord blood haematopoietic stem cells using thrombopoietin, Flt3-ligand, interleukin (IL)-6 and IL-11 in a serum-free and stroma-free culture system.

Authors:  L Lazzari; S Lucchi; P Rebulla; L Porretti; G Puglisi; L Lecchi; G Sirchia
Journal:  Br J Haematol       Date:  2001-02       Impact factor: 6.998

7.  Single administration of thrombopoietin to lethally irradiated mice prevents infectious and thrombotic events leading to mortality.

Authors:  M A Mouthon; M H Gaugler; A Van der Meeren; M Vandamme; P Gourmelon; G Wagemaker
Journal:  Exp Hematol       Date:  2001-01       Impact factor: 3.084

Review 8.  Post-irradiation approaches to treatment of radiation injuries in the context of radiological terrorism and radiation accidents: a review.

Authors:  J E Moulder
Journal:  Int J Radiat Biol       Date:  2004-01       Impact factor: 2.694

9.  Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation.

Authors:  Lynne M Ball; Maria Ester Bernardo; Helene Roelofs; Arjan Lankester; Angela Cometa; R Maarten Egeler; Franco Locatelli; Willem E Fibbe
Journal:  Blood       Date:  2007-07-16       Impact factor: 22.113

10.  Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells.

Authors:  K Le Blanc; H Samuelsson; B Gustafsson; M Remberger; B Sundberg; J Arvidson; P Ljungman; H Lönnies; S Nava; O Ringdén
Journal:  Leukemia       Date:  2007-05-31       Impact factor: 11.528

View more
  34 in total

Review 1.  Adult Mesenchymal Stem Cells and Radiation Injury.

Authors:  Juliann G Kiang
Journal:  Health Phys       Date:  2016-08       Impact factor: 1.316

2.  Bone marrow transplantation helps restore the intestinal mucosal barrier after total body irradiation in mice.

Authors:  Sarita Garg; Wenze Wang; Biju G Prabath; Marjan Boerma; Junru Wang; Daohong Zhou; Martin Hauer-Jensen
Journal:  Radiat Res       Date:  2014-02-25       Impact factor: 2.841

Review 3.  Consequences of irradiation on bone and marrow phenotypes, and its relation to disruption of hematopoietic precursors.

Authors:  Danielle E Green; Clinton T Rubin
Journal:  Bone       Date:  2014-03-05       Impact factor: 4.398

4.  Effects of combined radiation and burn injury on the renin-angiotensin system.

Authors:  Sachin S Jadhav; Natasha Sharma; Christopher J Meeks; Nicholas M Mordwinkin; Theresa B Espinoza; Norma R Roda; Gere S DiZerega; Colin K Hill; Stan G Louie; Kathleen E Rodgers
Journal:  Wound Repair Regen       Date:  2012-12-11       Impact factor: 3.617

5.  Macrophages Educated with Exosomes from Primed Mesenchymal Stem Cells Treat Acute Radiation Syndrome by Promoting Hematopoietic Recovery.

Authors:  John A Kink; Matthew H Forsberg; Sofiya Reshetylo; Soroush Besharat; Charlie J Childs; Jessica D Pederson; Annette Gendron-Fitzpatrick; Melissa Graham; Paul D Bates; Eric G Schmuck; Amish Raval; Peiman Hematti; Christian M Capitini
Journal:  Biol Blood Marrow Transplant       Date:  2019-08-05       Impact factor: 5.742

6.  The Protein Content of Extracellular Vesicles Derived from Expanded Human Umbilical Cord Blood-Derived CD133+ and Human Bone Marrow-Derived Mesenchymal Stem Cells Partially Explains Why both Sources are Advantageous for Regenerative Medicine.

Authors:  Addeli B B Angulski; Luiz G Capriglione; Michel Batista; Bruna H Marcon; Alexandra C Senegaglia; Marco A Stimamiglio; Alejandro Correa
Journal:  Stem Cell Rev Rep       Date:  2017-04       Impact factor: 5.739

7.  Potential for a pluripotent adult stem cell treatment for acute radiation sickness.

Authors:  Denis O Rodgerson; Bruce E Reidenberg; Alan G Harris; Andrew L Pecora
Journal:  World J Exp Med       Date:  2012-06-20

8.  Melanin nanoparticles (MNPs) provide protection against whole-body ɣ-irradiation in mice via restoration of hematopoietic tissues.

Authors:  Monira M Rageh; Reem H El-Gebaly; H Abou-Shady; Doaa G Amin
Journal:  Mol Cell Biochem       Date:  2014-10-10       Impact factor: 3.396

9.  Multiplacenta derived stem cell/cytokine treatment increases survival time in a mouse model with radiation-induced bone marrow damage.

Authors:  Jun Li; Yunfang Wei; Lei Yan; Rui Wang; Ying Zhang; Yingzhen Su; Zhaoyu Yang; Min Hu; Rui Qi; Hongbo Tan; Qiong Wu; Xudong Yin; Xinghua Pan
Journal:  Cytotechnology       Date:  2016-06-18       Impact factor: 2.058

10.  Multipotent adult progenitor cells improve the hematopoietic function in myelodysplasia.

Authors:  Valerie D Roobrouck; Esther Wolfs; Michel Delforge; Dorien Broekaert; Soumen Chakraborty; Kathleen Sels; Thomas Vanwelden; Bryan Holvoet; Larissa Lhoest; Satish Khurana; Shubham Pandey; Chloé Hoornaert; Peter Ponsaerts; Tom Struys; Nancy Boeckx; Peter Vandenberghe; Christophe M Deroose; Catherine M Verfaillie
Journal:  Cytotherapy       Date:  2017-06       Impact factor: 5.414

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.